Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

This publication has 39 references indexed in Scilit:

• Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs
  Gene Therapy, 1999
• The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia
  Seminars in Cancer Biology, 1996
• Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer
  Vaccine, 1996
• T Cell Proliferative Responses Against Human Papillomavirus Type 16 E7 Oncoprotein are Most Prominent in Cervical Intraepithelial Neoplasia Patients with a Persistent Viral Infection
  Journal of General Virology, 1996
• The Current Status of Therapeutic HPV Vaccine
  Annals of Medicine, 1996
• Identification of H‐2K^b Binding and Immunogenic Peptides from Human Papilloma Virus Tumour Antigens E6 and E7
  Scandinavian Journal of Immunology, 1995
• Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA
  Vaccine, 1995
• Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific
  Journal of General Virology, 1994
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene.
  The Journal of Experimental Medicine, 1989